Leukemia 37 , 16491659 (2023)
My view has not changed: BPC-157 lacks adequate human evidence for ulcerative colitis, Crohn's disease or "gut healing", and it should not replace established IBD treatment
Charles Kamen, MD Board-Certified Neurologist Founder, LiveNow Longevity What we treatSeven disciplines
To the extent viscosity considerations potentially limit the use of a syringe/needle delivery system, thermoreversible gels or post-administration viscosity-enhancing options are also envisioned, as well as alternative delivery systems, including pumps, microinjection devices and the like
It is used exclusively for scientific research, stored under controlled conditions, and is not approved for human or veterinary use